Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from REPRO-MED Systems ( (KRMD) ) is now available.
On November 19, 2025, REPRO-MED Systems entered into an Amended and Restated Manufacturing and Supply Agreement with Command Medical Products, Inc. This agreement, effective January 1, 2024, outlines the manufacturing and supply of subassemblies, needle sets, and tubing products, and will expire on December 31, 2026, with automatic renewals unless terminated by either party. It includes terms on pricing, payment, and purchase commitments, as well as provisions for delivery, inspection, warranties, and intellectual property.
The most recent analyst rating on (KRMD) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on REPRO-MED Systems stock, see the KRMD Stock Forecast page.
Spark’s Take on KRMD Stock
According to Spark, TipRanks’ AI Analyst, KRMD is a Neutral.
The overall score reflects strong technical momentum and positive earnings call highlights, offset by weak financial performance and valuation concerns. The company’s growth in international markets and strategic advancements are promising, but profitability and cash flow issues remain significant challenges.
To see Spark’s full report on KRMD stock, click here.
More about REPRO-MED Systems
Average Trading Volume: 99,484
Technical Sentiment Signal: Buy
Current Market Cap: $226.5M
For a thorough assessment of KRMD stock, go to TipRanks’ Stock Analysis page.